clinical trial · NCT05678010
A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer
Solid TumorMetastatic Solid TumorSolid CarcinomaSolid Tumor, AdultMetastatic TumorMetastatic CancerAZD1390Stereotactic Body Radiotherapy
brief summary
The purpose of this study is to find out whether AZD1390 combined with stereotactic body radiation therapy/SBRT is a safe treatment for people with metastatic solid tumor cancer
started
May 17, 2023
primary completion
May 17, 2028
completion
May 17, 2028
last updated
May 18, 2025
official title
A Phase I Study Assessing the Safety and Tolerability of Ascending Doses of AZD1390 in Combination With Stereotactic Body Radiation Therapy (SBRT) in Patients With Metastatic Solid Tumor Malignancies
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol